Baduanjin exercise practice improves outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention procedures

A comprehensive systematic review and meta-analysis evaluated the efficacy of Baduanjin, a traditional Chinese mind-body exercise, in patients with acute myocardial infarction undergoing percutaneous coronary intervention. The analysis pooled data from multiple randomized controlled trials involving 1,293 participants, comprising 870 males and 423 females. This extensive evaluation aimed to determine whether this specific exercise regimen offered clinically meaningful benefits beyond standard cardiac care protocols. The study design focused on rigorous assessment of both physiological and psychological outcomes to inform clinical practice guidelines for post-infarction rehabilitation.

The primary analysis revealed substantial improvements in left ventricular ejection fraction among participants practicing Baduanjin. The pooled mean difference indicated a significant increase of 6.20 percentage points compared to control groups, with a 95% confidence interval ranging from 3.14 to 9.25. This improvement was statistically robust, with a p-value less than 0.0001, suggesting a strong association between the intervention and enhanced cardiac pump function. Such gains in ejection fraction are critical for reducing heart failure risk and improving long-term prognosis in this vulnerable patient population.

Functional capacity assessments demonstrated equally impressive results through measurements of the 6-minute walk distance. Participants in the intervention group walked an average of 60.21 meters further than controls, with a confidence interval of 17.96 to 102.46 meters. This improvement in physical endurance reflects better overall cardiovascular fitness and reduced fatigue, allowing patients to engage more fully in daily activities. The statistical significance of this finding, with a p-value of 0.005, underscores the tangible impact of the exercise regimen on physical performance.

Quality of life metrics across three distinct validated instruments showed consistent and clinically meaningful enhancements. Scores on the Seattle Angina Questionnaire improved by 11.36 points, while the Angina Pectoris Quality of Life Questionnaire and WHOQOL-BREF also demonstrated significant gains. These improvements indicate that patients experienced less angina-related discomfort and better overall well-being. The consistency of results across different measurement tools strengthens the evidence for Baduanjin's role in holistic patient recovery.

Psychological outcomes were equally notable, with significant reductions in anxiety and depression scores. Anxiety assessments using the Hamilton Anxiety Rating Scale and Generalized Anxiety Disorder-7 showed mean reductions of 1.40 and 2.67 points respectively. Depression scores on the Hamilton Depression Rating Scale and Patient Health Questionnaire-9 decreased by 2.80 and 2.73 points. These mental health benefits are crucial for patients facing the emotional toll of heart disease and invasive procedures.

Safety and tolerability profiles were favorable throughout the study period. The incidence of cardiovascular adverse events was reduced by 60% in the intervention group, with a relative risk of 0.40. No serious adverse events or discontinuations were reported, suggesting that Baduanjin is safe for this patient population. The absence of increased risk for adverse events supports its integration into standard rehabilitation programs without safety concerns.

Despite these promising findings, the authors acknowledge the need for further well-designed studies to confirm efficacy. The current evidence, while robust, relies on existing trial data that may have limitations in generalizability. Future research should aim to replicate these results in diverse populations and settings to solidify the evidence base. Until then, clinicians should consider Baduanjin as a potential adjunctive therapy for managing and rehabilitating patients with acute myocardial infarction.

In conclusion, Baduanjin exercise represents a promising non-pharmacological intervention for patients recovering from acute myocardial infarction. Its ability to improve cardiac function, physical endurance, quality of life, and mental health makes it a valuable addition to comprehensive care plans. Clinicians should consider recommending this practice as part of a multidisciplinary approach to optimize patient outcomes and support long-term recovery.